As new targets designed to help the EU economy work towards autonomy are unveiled, Europe’s “old growth” model and its R&D multinationals’ reliance on foreign markets come under review.
- Professor in Strategic Management and Innovation, ESCP Business School
Research found Big Pharma companies with global reach more likely to abide by environmental standards.
Les multinationales dont les ventes et les actifs sont répartis uniformément dans le monde sont moins nombreuses et plus vulnérables qu’on ne le pense.
Contact Regis for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- Joined
